These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22918724)

  • 1. A rational approach to selective pharmacophore designing: an innovative strategy for specific recognition of Gsk3β.
    Pradeep H; Rajanikant GK
    Mol Divers; 2012 Aug; 16(3):553-62. PubMed ID: 22918724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis of valmerins as dual inhibitors of GSK3β/CDK5.
    Li X; Wang X; Tian Z; Zhao H; Liang D; Li W; Qiu Y; Lu S
    J Mol Model; 2014 Sep; 20(9):2407. PubMed ID: 25142337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of dual kinase inhibitors of CK2 and GSK3β: combined qualitative and quantitative pharmacophore modeling approach.
    Pardhi T; Vasu K
    J Biomol Struct Dyn; 2018 Jan; 36(1):177-194. PubMed ID: 27960601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational design of potent GSK3beta inhibitors with selectivity for Cdk1 and Cdk2.
    Lesuisse D; Dutruc-Rosset G; Tiraboschi G; Dreyer MK; Maignan S; Chevalier A; Halley F; Bertrand P; Burgevin MC; Quarteronet D; Rooney T
    Bioorg Med Chem Lett; 2010 Mar; 20(6):1985-9. PubMed ID: 20167481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Docking and quantitative structure-activity relationship of oxadiazole derivates as inhibitors of GSK3β.
    Quesada-Romero L; Caballero J
    Mol Divers; 2014 Feb; 18(1):149-59. PubMed ID: 24081608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theoretical Studies on the Selectivity Mechanisms of Glycogen Synthase Kinase 3β (GSK3β) with Pyrazine ATP-competitive Inhibitors by 3DQSAR, Molecular Docking, Molecular Dynamics Simulation and Free Energy Calculations.
    Zhu J; Wu Y; Xu L; Jin J
    Curr Comput Aided Drug Des; 2020; 16(1):17-30. PubMed ID: 31284868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and in vitro evaluation of new leads as selective and competitive glycogen synthase kinase-3β inhibitors through ligand and structure based drug design.
    Darshit BS; Balaji B; Rani P; Ramanathan M
    J Mol Graph Model; 2014 Sep; 53():31-47. PubMed ID: 25064440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and Design of Novel Small Molecule GSK-3 Inhibitors Targeting the Substrate Binding Site.
    Rippin I; Khazanov N; Shirley Ben Joseph ; Kudinov T; Berent E; Arciniegas Ruiz SM; Marciano D; Levy L; Gruzman A; Senderowitz H; Eldar-Finkelman H
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33218072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of bridging water molecules in GSK3β-inhibitor complexes: insights from QM/MM, MD, and molecular docking studies.
    Lu SY; Jiang YJ; Lv J; Zou JW; Wu TX
    J Comput Chem; 2011 Jul; 32(9):1907-18. PubMed ID: 21469159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fragment and knowledge-based design of selective GSK-3beta inhibitors using virtual screening models.
    Vadivelan S; Sinha BN; Tajne S; Jagarlapudi SA
    Eur J Med Chem; 2009 Jun; 44(6):2361-71. PubMed ID: 18929433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural features underlying selective inhibition of GSK3β by dibromocantharelline: implications for rational drug design.
    Zhang N; Zhong R; Yan H; Jiang Y
    Chem Biol Drug Des; 2011 Mar; 77(3):199-205. PubMed ID: 21244636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new protocol for predicting novel GSK-3β ATP competitive inhibitors.
    Fang J; Huang D; Zhao W; Ge H; Luo HB; Xu J
    J Chem Inf Model; 2011 Jun; 51(6):1431-8. PubMed ID: 21615159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of Potent ALK Inhibitors Using Pharmacophore-Informatics Strategy.
    James N; Ramanathan K
    Cell Biochem Biophys; 2018 Jun; 76(1-2):111-124. PubMed ID: 28477056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of Fragment-Based de Novo Design to the Discovery of Selective Picomolar Inhibitors of Glycogen Synthase Kinase-3 Beta.
    Park H; Shin Y; Kim J; Hong S
    J Med Chem; 2016 Oct; 59(19):9018-9034. PubMed ID: 27676184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based approaches to improve selectivity: CDK2-GSK3beta binding site analysis.
    Vulpetti A; Crivori P; Cameron A; Bertrand J; Brasca MG; D'Alessio R; Pevarello P
    J Chem Inf Model; 2005; 45(5):1282-90. PubMed ID: 16180905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-Aryl-4-(arylhydrazono)-1H-pyrazol-5-ones: Highly ligand efficient and potent inhibitors of GSK3beta.
    Arnost M; Pierce A; ter Haar E; Lauffer D; Madden J; Tanner K; Green J
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1661-4. PubMed ID: 20138514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Glycogen Synthase Kinase Inhibitors That Regulate Cytochrome P450 Expression in Primary Human Hepatocytes by Activation of β-Catenin, Aryl Hydrocarbon Receptor and Pregnane X Receptor Signaling.
    Briolotti P; Chaloin L; Balaguer P; Da Silva F; Tománková V; Pascussi JM; Duret C; Fabre JM; Ramos J; Klieber S; Maurel P; Daujat-Chavanieu M; Gerbal-Chaloin S
    Toxicol Sci; 2015 Nov; 148(1):261-75. PubMed ID: 26259606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational design of new protein kinase D 1 (PKD1) inhibitors: homology-based active site prediction, energy-optimized pharmacophore, docking and database screening.
    Nalini ; Chadha N; Bahia MS; Kaur M; Bahadur R; Silakari O
    Mol Divers; 2018 Feb; 22(1):47-56. PubMed ID: 29058231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of two potential glycogen synthase kinase 3β inhibitors for the treatment of osteosarcoma.
    Lu K; Wang X; Chen Y; Liang D; Luo H; Long L; Hu Z; Bao J
    Acta Biochim Biophys Sin (Shanghai); 2018 May; 50(5):456-464. PubMed ID: 29546355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationship of the 7-hydroxy benzimidazole analogs as glycogen synthase kinase 3β inhibitor.
    Lee SC; Shin D; Cho JM; Ro S; Suh YG
    Bioorg Med Chem Lett; 2012 Mar; 22(5):1891-4. PubMed ID: 22325951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.